Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 8,533 $ 6,816
Restricted cash 250
Marketable debt securities, available for sale 14,114 1,639
Marketable equity securities, at fair value 214
Accounts receivable, net 10,680 3,155
Inventory, net 8,510 3,039
Prepaid expenses and other current assets 1,602 1,238
Total current assets 43,903 15,887
Property, plant and equipment, net 6,454 3,578
Secured promissory note receivable 3,774 2,750
Prepaid expenses, net of current portion 460 2,084
Right-of-use asset, net 4,484 4,731
Intangible assets, net 11,562 1,234
Goodwill 1,385 901
Other assets 608 240
TOTAL ASSETS 72,630 31,405
Current liabilities    
Accounts payable 2,394 3,771
Accrued diagnostic services 3,260
Accrued advertising and other allowances 344 463
Lease liabilities 676 329
Deferred revenue 1,517
Other current liabilities 1,741 1,731
Total current liabilities 9,932 6,294
Non-current liabilities:    
Deferred revenue, net of current portion 106 162
Note payable 81
Unsecured convertible promissory notes, net 9,995 9,991
Lease liabilities, net of current portion 4,252 4,402
Total non-current liabilities 14,434 14,555
Total liabilities 24,366 20,849
Stockholders’ equity    
Preferred stock authorized 1,000,000, $.0005 par value, no shares issued and outstanding
Common stock authorized 50,000,000, $.0005 par value, 15,652,724 and 11,604,253 shares outstanding, respectively 16 14
Additional paid-in capital 103,807 61,674
Accumulated deficit (7,947) (3,631)
Treasury stock, at cost, 16,652,022 and 16,652,022 shares, respectively (47,490) (47,490)
Accumulated other comprehensive loss (122) (11)
Total stockholders’ equity 48,264 10,556
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 72,630 $ 31,405